Effect of PCSK9 Inhibitor on Early Neurological Deterioration in Stroke Patients
Author Information
Author(s): Gong Xing, Yu Xinting, Pu Lanlan, Jiao Yang, Liu Lin, Cao Hua, Ji Xiaofei
Primary Institution: First Affiliated Hospital of Dalian Medical University
Hypothesis
This study aims to evaluate how effective PCSK9 inhibitors are in reducing early neurological deterioration among acute ischemic stroke patients with coronary heart disease.
Conclusion
The study will investigate the potential benefits of PCSK9 inhibitors in preventing early neurological deterioration in high-risk stroke patients.
Supporting Evidence
- The study aims to provide new insights for treatment strategies in stroke patients with coronary heart disease.
- PCSK9 inhibitors may help reduce early neurological deterioration by lowering LDL cholesterol levels.
Takeaway
This study is looking at whether a new medicine can help stroke patients who also have heart problems feel better and recover faster.
Methodology
This is a prospective, randomized, parallel-group, blinded-endpoint, single-center clinical study involving 156 patients.
Limitations
The study is limited by its single-center design and relatively small sample size, which may affect the generalizability of the results.
Participant Demographics
Participants will be aged between 18 and 80 years, with a history of coronary heart disease and acute ischemic stroke.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website